Analysis of Anthropic's Long-Term Benefit Trust Structure and Member Expertise

Trust Structure and Power

Anthropic operates as a Delaware Public Benefit Corporation, allowing its board to prioritize public benefit over shareholder returns. The Long-Term Benefit Trust (LTBT) holds Class T shares worth $0 (no equity, dividends, or liquidation preference) but retains the power to appoint a majority of the board. As of April 2026, three of six directors are Trust-appointed.

Trustee Profiles

The current trustees are:

• Dr. Neil Buddy Shah (Chair, since Sept 2023): CEO of Clinton Health Access Initiative and former GiveWell Managing Director. His background is in global health and evidence-based resource allocation, not AI.
• Richard Fontaine (since May 2025): CEO of the Center for a New American Security. He brings national security and policy expertise but lacks fiduciary oversight experience for commercial entities.
• Dr. Ben Bernanke (since July 2026): Nobel Prize in Economic Sciences (2022) and former Federal Reserve Chair. Appointed to address AI's economic impact, his expertise is macroeconomic rather than technical AI safety.

Structural Critique

The analysis highlights a structural bull case where trustees' reputational capital and the PBC legal framework protect safety-first decisions. However, the bear case notes that the charter includes "failsafe" provisions allowing stockholder supermajorities to override the Trust without trustee consent. Additionally, the Trust shrank from five to three members in January 2026, and none of the current members have published backgrounds in AI safety research (alignment, interpretability, or AI risk).

Pending Disclosures

The full Trust Agreement, including exact override thresholds and enforcement mechanics, remains unpublished. Anthropic confidentially filed its S-1 on June 1, 2026, where complete governance terms are expected to be disclosed.